MSFIRST - utilising a longitudinal, prospective, comparative drug safety module for use in everyday MS clinical practice to evaluate and track incidence and characteristics of safety outcomes in MS patients on therapy over the long term

J. Haartsen, T. Spelman, J. Baker, S. Agland, J. Lechner-Scott, T. Burke, S. Vucic, L. Rath, O. Skibina, M. Toubia, M. Slee, S. McGregor, B. Taylor, A. O'Connell, M. Barnett, S. Baker, M. Sharma, S. Hodgkinson, S. Walters, A. KermodeW. Hayes, E. Butler, N. Shuey, C. Shaw, R. Portley, T. Hardy, I. L. Tan, H. Butzkueven

Research output: Contribution to journalAbstract/Meeting Abstract

Original languageEnglish
Pages (from-to)342-343
JournalMultiple Sclerosis Journal
Volume22
Publication statusPublished - 2016

Cite this